Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00122980 · ClinicalTrials.gov registry record · Phase 3
Stroke With Transfusions Changing to Hydroxyurea
A Phase 3 study, sponsored by St. Jude Children's Research Hospital.
- Terminated
- Registry status
- Phase 3
- Development phase
- 134
- Enrollment target
NCT00122980 is a Phase 3 study that was terminated before completion, run by St. Jude Children's Research Hospital. The registered enrollment target is 134 participants.
The verdict
NCT00122980, a Phase 3 study, was terminated before completion, sponsored by St. Jude Children's Research Hospital.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 134 participants
- Enrollment target
Study Summary
The purpose of this study is to compare standard therapy (transfusions and chelation) with alternative therapy (hydroxyurea and phlebotomy) for the prevention of secondary stroke and management of iron overload in children with sickle cell anemia (SCA).
Interventions
- DRUG Hydroxyurea
- PROCEDURE Phlebotomy
- PROCEDURE Red Cell Transfusions
- PROCEDURE Iron Chelation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2006-10 |
| Est. Completion | 2010-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00122980
The ClinicalTrials.gov registry entry for NCT00122980 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 134 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Hydroxyurea is the first listed.
NCT00122980 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00122980 about?
NCT00122980 is a clinical study titled "Stroke With Transfusions Changing to Hydroxyurea". The purpose of this study is to compare standard therapy (transfusions and chelation) with alternative therapy (hydroxyurea and phlebotomy) for the prevention of secondary stroke and management of iron overload in children with sickle cell anemia (SCA).
What is the current status of trial NCT00122980?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 134 participants. The study started on 2006-10. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00122980?
The interventions under investigation include: Hydroxyurea (DRUG), Phlebotomy (PROCEDURE), Red Cell Transfusions (PROCEDURE), Iron Chelation (PROCEDURE).
Who is sponsoring clinical trial NCT00122980?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.